SI Joint Fusion: Approaches, Candidates, and Recovery
SI joint fusion is a later option for carefully selected sacroiliac (SI) joint pain—not a first step for every buttock or low-back ache. This page is the parent guide to fusion approaches used at SpinePain Solutions, including how candidacy is built, how diagnostic injections and radiofrequency ablation fit the pathway, and where device pages go into detail. Condition overview: sacroiliac joint dysfunction. Related reading: sciatica vs SI joint pain.
Quick Answer: SI Joint Fusion
- Goal: stabilize a carefully selected painful SI joint while bone heals—not treat every cause of low-back pain.
- SI joint fusion surgery is discussed only after conservative care and a convincing diagnostic pathway—not as a first step.
- Approaches in plain terms: lateral/posterolateral (transiliac) fixation that crosses the joint vs a posterior corridor that places a structural allograft inside the joint.
- Dr. Amit Sharma performs SI joint fusion himself, uses bone graft in every case, and chooses the approach and implant with you based on anatomy and goals. The systems most commonly used at our practice are SacriX and LinQ.
- Other systems can fit some patients. When SacriX or LinQ is chosen, SacriX (screw-based) is often preferred for stability; LinQ is a posterior option without screws for patients who prefer that after shared discussion.
- Diagnosis needs history, exam, imaging, and usually diagnostic SI joint blocks. Conservative care comes first.
- A helpful injection does not automatically mean fusion is next. Sudden severe weakness or new bowel or bladder loss is an emergency—call 911.
What SI Joint Fusion Means
SI joint fusion places an implant or structural graft so a selected sacroiliac joint can stabilize while bone heals across the joint. Goals, recovery, and risks differ from a needle injection. Fusion may reduce pain from the treated joint without eliminating lumbar spine, hip, or nerve pain from other sources.
Dr. Sharma performs the procedure himself. Bone graft is used in every case. The work is done in a hospital or surgery center setting. Sedation may range from none or local anesthetic only to Versed (conscious sedation) or MAC with propofol—individualized. Arrange a driver when sedation is used.
Approaches: Lateral or Posterolateral vs Posterior
Several corridors are discussed in plain language—including lateral or posterolateral (transiliac) paths and posterior paths. Other implant designs exist. Names vary by manufacturer and paper, so ask which exact path and implant are planned for you. The choice depends on your anatomy and the discussion with Dr. Sharma.
Lateral or posterolateral (transiliac) approaches
These corridors place fixation that crosses the SI joint—often described as lateral-oblique or posterolateral-medial-oblique. The idea is initial mechanical stability across the joint while fusion develops. Screws or similar fixation devices are common in this family. At SpinePain Solutions, the SacriX system is the screw-based option in this group. Detail: SacriX SI joint fusion.
Posterior (intra-articular) approaches
A posterior corridor places a structural implant—often a cortical bone allograft—within the joint rather than driving metal screws across it. Recovery still includes wound care and activity limits while bone heals. At SpinePain Solutions, LinQ is the posterior allograft option without screws. Detail: LinQ SI joint fusion.
No corridor or implant is “best for everyone.” Anatomy, bone quality, prior pelvic or spine surgery, existing implants, goals, and how you weigh stability versus avoiding screws all matter. Results from one implant family should not be copied onto another. Other systems beyond those detailed below may be appropriate for some patients.
Implant Systems Most Commonly Used at Our Practice
Dr. Sharma keeps implant choice open and reviews options with each patient. The systems most commonly used at our practice are SacriX and LinQ; other systems may fit some anatomies after discussion. When SacriX is chosen, it is often preferred because its screws are designed to cross the joint and help hold it steady while fusion heals. Some patients would rather avoid the word or feel of screws; LinQ is a screw-free bone-graft option among the systems we use most often. He explains open questions—including that published evidence shapes differ—before a patient decides. This is his practice approach, not a claim that one system works better for every person, and it does not disparage any company.
| Factor | SacriX | LinQ |
|---|---|---|
| Corridor | Lateral-oblique / transiliac | Posterior intra-articular |
| Implant | Titanium screws across the joint | Structural cortical allograft in the joint |
| Regulatory shape | FDA 510(k) K232605 (cleared, not “approved”) | HCT/P allograft pathway (21 CFR 1271 / section 361)—not a 510(k) metal device |
| Evidence shape | More comparative literature for lateral/transiliac overall; mixed and device-specific | Growing prospective series (for example SECURE); less mature than lateral transiliac trial literature overall |
| Use here | Among the systems most commonly used here; often preferred for joint stability when selected | Among the systems most commonly used here; option when a patient prefers no screws, after reviewing tradeoffs |
SacriX (SacriX® Sacroiliac Joint Fusion Device System, LESspine Innovations) is FDA-cleared under 510(k) K232605 (September 28, 2023). Labeling describes intended use for fusion of the sacroiliac joint for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. Clearance is not a promise of individual success.
LinQ (PainTEQ) places a structural cortical bone allograft within the joint through a posterior corridor. Peer-reviewed reports describe this implant under the FDA human cells and tissues (HCT/P) framework (21 CFR 1271 / section 361), not as an FDA-cleared or FDA-approved 510(k)/PMA metal fixation device. That tissue pathway focuses on communicable-disease controls and is not the same as device clearance reviewing effectiveness. This page also does not claim a separate 510(k) for LinQ delivery instruments. Do not treat lateral-transiliac trial results as proof for LinQ, or the reverse.
Conservative Care Comes First
Fusion is not a first step for ordinary buttock or low-back pain. Most people start without a procedure when there is no emergency:
- Physical therapy for pelvic control, walking tolerance, and helpful postures.
- Activity pacing and sleep-position changes that reduce flare-ups.
- Medicines chosen for your age and other conditions.
- Partner care with physical therapists and chiropractors when that fits your plan.
If limits remain after a fair try, an image-guided diagnostic injection may clarify the next step—not an automatic jump to an implant.
How Doctors Confirm the SI Joint Is the Pain Source
Pain from the SI region can overlap with lumbar spine, hip, and nerve-root problems. Evaluation usually includes pain history, exam, several SI provocation maneuvers that reproduce the familiar pain, and assessment of the lumbar spine and hips. Imaging can find fracture, infection, inflammatory disease, or a competing diagnosis. Routine degenerative changes alone do not prove the SI joint is the source.
Image-guided diagnostic injection
When the result will change the plan, an image-guided local-anesthetic injection can add diagnostic evidence. The most useful response occurs during the expected anesthetic window while repeating a normally painful activity. See fluoroscopy during SI injection and the injection procedure page.
There is no single percentage that is every doctor’s universal rule. Timing, technical accuracy, activity tested, and purpose of the block matter. A clear response supports the diagnosis. It does not guarantee fusion success. A modest or unclear response should reopen competing causes.
Diagnostic Block to Fusion Pathway
| Step | What it is | Useful result (plain language) | Typical next thought |
|---|---|---|---|
| Conservative care | PT, activity changes, medicines when safe; partner care as appropriate | Function improving—or still limited after a fair try | Continue care vs add diagnostic injection |
| Image-guided SI injection | Local anesthetic ± steroid (an off-label use in the SI joint) under fluoroscopy/CT | Clear improvement in the usual pain during the expected window, ideally during a normally painful activity | Therapeutic course vs stronger evidence the joint is the source |
| Reassess competing causes | Lumbar, hip, neurologic, inflammatory | Another source more likely—or SI still most convincing | Treat that source first, or continue SI pathway |
| Selected RFA (when appropriate) | Nerve-targeted radiofrequency for posterior SI complex pain | Meaningful relief without needing joint stabilization | Continue non-fusion care; reassess if relief is short-lived |
| Discuss fusion | Discuss implant and approach (SacriX and LinQ are most commonly used here) when candidacy fits | Joint still most convincing source; limits remain meaningful | Shared decision on approach, sedation, recovery |
When SI Joint Fusion May Be Discussed
Fusion may be discussed when persistent, function-limiting pain has been reasonably localized to the SI joint, appropriate nonsurgical care has not provided enough improvement, competing lumbar and hip conditions have been evaluated, and an image-guided diagnostic injection provides convincing improvement. No single symptom, test, scan, or injection percentage establishes candidacy by itself.
Supporting clues include pain below L5 in an SI pattern, meaningful limits on walking, standing, sleep, or work, provocation maneuvers that reproduce the usual pain, and a strong activity-correlated injection response. Reasons to pause include acute or improving pain, weak injection documentation, untreated radiculopathy or hip disease, infection, or expecting total pain elimination as a personal guarantee.
SI Joint Injection Within the Fusion Pathway
An SI joint injection places local anesthetic, and sometimes a steroid (an off-label use in the SI joint), into or around the joint under image guidance. The near-term goal is to learn whether that joint produces your familiar pain. Some people also feel quieter symptoms for a period. The joint is not fused.
| Topic | SI joint injection | SI joint fusion |
|---|---|---|
| Main goal | Confirm the pain source; sometimes calm irritation | Stabilize a carefully selected painful joint |
| Implant / graft | None | Implant or graft (at our practice, most often SacriX screws or LinQ allograft; other systems may fit some patients) |
| Sedation range | None, local only, Versed, or MAC with propofol—individualized | Same range options—individualized |
| Recovery shape | Usually short; no bone-healing period | Wound care, activity limits, months of healing |
A helpful injection does not automatically mean fusion is required. An unclear response should prompt another look at the diagnosis rather than rushing to an implant. Full how-to detail lives on the sacroiliac joint injection page.
Radiofrequency Ablation vs Fusion
Radiofrequency ablation (RFA) reduces pain signals from selected nerves around the posterior SI complex. It does not fuse the joint. Fusion stabilizes a selected joint and needs surgical recovery. An intra-articular diagnostic injection for fusion and prognostic nerve blocks for RFA are not the same pathway.
RFA may fit persistent posterior SI-complex pain after conservative care when prognostic blocks support the target. Fusion may fit when the candidacy assessment above is convincing. Failed RFA does not automatically mean fusion. Comparative trials reported cooled RFA improved selected outcomes versus standard medical management in selected patients; those trials did not compare RFA with fusion. Overview: radiofrequency ablation.
What the Evidence Shows—and What It Cannot Prove
Pragmatic randomized studies have reported improvement after minimally invasive SI fusion versus nonsurgical care in selected patients with triangular titanium implants. A 2024 double-blind trial of minimally invasive fusion with triangular titanium implants did not show superiority over sham surgery at six months. Multispecialty consensus characterizes lateral MIS fusion evidence as conflicting and posterior fusion evidence as lower certainty. Society statements outline diagnostic-block pathways for selected patients. Posterior allograft series such as SECURE add prospective data but are not sham-controlled head-to-head RCTs against lateral implants. Device-specific results should not be generalized.
Careful selection reduces uncertainty. It does not predict one person’s result. Fusion may reduce treated-joint pain without eliminating lumbar, hip, or nerve pain.
Recovery After Fusion
Many patients go home the same day from a hospital or surgery center and begin short walks early, sometimes with crutches or a walker. Light activity may resume over weeks; unrestricted activity and biological fusion can take months. Patients should not assume identical weight-bearing or return-to-work plans across different approaches or implant systems. Early pain improvement does not prove fusion is complete. Driving waits until you are off impairing medicines and the team clears you. Written instructions from Dr. Sharma’s team come first.
- Use a walker or crutches if prescribed and follow the exact weight-bearing plan.
- Keep the incision protected and follow individualized showering instructions.
- Limit lifting, bending, twisting, and exercise as directed.
- Begin rehabilitation only according to the operating clinician’s protocol.
- Expect return-to-work decisions to depend on commuting, sitting tolerance, and physical job demands.
Alternatives if Fusion Is Not the Next Step
Options may include ongoing rehab, therapeutic SI injection, selected sacral lateral-branch RFA, treatment of lumbar or hip sources, evaluation of inflammatory sacroiliitis, and continued nonsurgical care. Optional PRP discussion for the SI joint is covered on our PRP for SI joint pain page and is not required for the injection–fusion pathway.
Risks and Warning Signs
Fusion risks include infection, bleeding, nerve irritation or injury, implant or graft malposition or loosening, fracture, persistent pain, nonunion, adjacent pelvic or lumbar pain, anesthesia issues, and possible revision. Transiliac and posterior approaches have different technical concerns. Neither list predicts one outcome.
Call 911 or go to the nearest emergency room for sudden severe leg weakness, new loss of bladder or bowel control, numbness in the saddle area, chest pain, or shortness of breath. Contact the team promptly for fever, drainage, spreading redness, wound opening, uncontrolled pain, or new weakness after a procedure. Call 631-310-0000 for non-emergency questions.
Care at SpinePain Solutions
Dr. Amit Sharma, Chief, Division of Pain Medicine at Good Samaritan University Hospital, reviews symptoms, imaging, and prior care at our Bay Shore, Commack, and Farmingdale offices (office locations). He performs SI joint fusion himself, uses bone graft in every case, and keeps implant choice open based on anatomy and goals. The systems most commonly used at our practice are SacriX and LinQ. Call or text 631-310-0000.
Frequently Asked Questions
What is SI joint fusion?
SI joint fusion is a procedure that places an implant or structural bone graft to stabilize a carefully selected painful sacroiliac joint while bone heals. It is considered after conservative care and after the joint has been reasonably confirmed as the pain source—often with image-guided diagnostic injections. It is not a first step for ordinary low-back or buttock pain.
When is SI joint pain an emergency?
Call 911 or go to the nearest emergency room for sudden severe leg weakness, new loss of bladder or bowel control, numbness in the saddle area, fever with severe back or pelvic pain, or rapidly worsening neurologic change. Elective discussion of fusion approaches is not for those emergencies. Call SpinePain Solutions at 631-310-0000 for non-emergency questions.
What approaches are used for SI joint fusion?
Several corridors are discussed in plain language, including a lateral or posterolateral (transiliac) approach that places fixation across the joint and a posterior approach that places a structural allograft within the joint. Other implant systems exist. At SpinePain Solutions, the systems most commonly used are SacriX (screw-based) and LinQ (posterior allograft without screws). The choice depends on your anatomy and the discussion with Dr. Sharma. Detail pages explain SacriX and LinQ.
How do doctors confirm the SI joint is the pain source?
Confirmation usually combines history, exam with SI provocation maneuvers, imaging to look for competing problems, and often an image-guided diagnostic SI joint injection with local anesthetic. A clear response during the anesthetic window supports the diagnosis. It does not guarantee fusion success. An unclear response should reopen lumbar and hip causes.
What is the difference between an SI joint injection and SI joint fusion?
An SI joint injection places medicine into or around the joint under image guidance to help confirm whether that joint produces familiar pain and sometimes to calm irritation for a time. Steroid in the SI joint is an off-label use. Fusion places an implant or graft to stabilize the joint and needs surgical recovery and bone healing. A helpful injection does not automatically mean fusion is next.
Does Dr. Sharma perform SI joint fusion?
Yes. Amit Sharma, MD, Chief, Division of Pain Medicine at Good Samaritan University Hospital, performs SI joint fusion himself. He uses bone graft in every case and keeps implant choice open based on anatomy and goals. The systems most commonly used at our practice are SacriX and LinQ. Offices are in Bay Shore, Commack, and Farmingdale. Call 631-310-0000.
What is the difference between SacriX and LinQ?
SacriX and LinQ are the systems most commonly used at our practice—not the only systems that exist. SacriX is an FDA-cleared titanium screw system used from a lateral-oblique corridor that crosses the SI joint. LinQ is a posterior approach that places a structural cortical bone allograft within the joint; peer-reviewed reports describe it under the human tissue (HCT/P) pathway rather than as an FDA-cleared 510(k) metal implant. They are different tools. When they are the options under discussion, Dr. Sharma often prefers SacriX for stability and offers LinQ for patients who prefer to avoid screws after reviewing tradeoffs.
Is radiofrequency ablation the same as SI joint fusion?
No. SI joint radiofrequency ablation reduces pain signals from selected nerves around the posterior SI joint complex. It does not stabilize or fuse the joint. Fusion aims to stabilize a carefully selected painful joint and needs surgical recovery and bone healing. Failed RFA does not automatically mean fusion is needed.
Dr. Amit Sharma & our minimally invasive pain & spine team.
Medical References
- Polly DW, et al. Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion Using Triangular Titanium Implants vs Nonsurgical Management… Neurosurgery. 2015. PMID 26291338.
- Randers EM, et al. The effect of minimally invasive sacroiliac joint fusion compared to sham operation… EClinicalMedicine. 2024. PMID 38328752.
- McCormick ZL, et al. Consensus practice guidelines on sacroiliac joint complex pain… Reg Anesth Pain Med. 2025. PMID 41320235.
- Lorio M, et al. ISASS Policy 2020 Update—Minimally Invasive Surgical Sacroiliac Joint Fusion… Int J Spine Surg. 2020. PMID 33560247.
- Sayed D, et al. ASPN Best Practice Guideline for the Treatment of Sacroiliac Disorders. J Pain Res. 2024. PMID 38716038.
- Calodney A, et al. SECURE: Posterior Sacroiliac Fusion Allograft Implant (LinQ). J Pain Res. 2024. PMID 38524688.
- Calodney A, et al. Six-month interim outcomes from SECURE… Expert Rev Med Devices. 2022. PMID 35724479.
- Cohen SP, et al. Cooled RFA versus standard medical management for chronic SI joint pain. Reg Anesth Pain Med. 2024. PMID 37407279.
- Cohen SP, et al. Cooled RFA 12-month follow-up… Reg Anesth Pain Med. 2025/2026. PMID 40089310.
- U.S. FDA. 510(k) K232605: SacriX® Sacroiliac Joint Fusion Device System. Decision September 28, 2023. LESspine Innovations. FDA record.
Dr. Amit Sharma, Chief, Division of Pain Medicine



